...
首页> 外文期刊>Clinical Microbiology Newsletter >The Individualized Quality Control Plan— Coming Soon to Clinical Microbiology Laboratories Everywhere!
【24h】

The Individualized Quality Control Plan— Coming Soon to Clinical Microbiology Laboratories Everywhere!

机译:个性化的质量控制计划-即将在各地的临床微生物实验室中使用!

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

As of 1 January 2016, microbiology laboratories can choose to adopt a new quality control option, the Individualized Quality Control Plan (IQCP), under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). This voluntary approach increases flexibility for meeting regulatory requirements and provides laboratories the opportunity to customize QC for testing in their unique environments and with their testing personnel. IQCP is an all-inclusive approach to quality based on risk management to address potential errors in the total testing process. It includes three main steps: (i) performing a risk assessment, (ii) developing a QC plan, and (iii) monitoring the plan through quality assessment. Resources are available from the Centers for Medicare & Medicaid Services, Centers for Disease Control and Prevention, American Society for Microbiology, Clinical and Laboratory Standards Institute, and accrediting organizations, such as the College of American Pathologists and Joint Commission, to assist microbiology laboratories implementing IQCP.
机译:从2016年1月1日起,根据1988年临床实验室改进修正案(CLIA),微生物实验室可以选择采用新的质量控制方案,即个性化质量控制计划(IQCP)。这种自愿的方法增加了满足法规要求的灵活性,并为实验室提供了在其独特的环境中及其测试人员针对测试进行自定义QC的机会。 IQCP是一种基于风险管理的全面质量检查方法,可以解决整个测试过程中的潜在错误。它包括三个主要步骤:(i)进行风险评估,(ii)制定质量控制计划,以及(iii)通过质量评估监控计划。资源可从医疗保险和医疗补助服务中心,疾病控制与预防中心,美国微生物学会,临床和实验室标准协会以及美国病理学家学院和联合委员会等认可组织获得,以协助微生物实验室实施IQCP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号